Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity ...
As experts warn that flu season may start earlier this year, they say over-the-counter generic drugs may offer the same ...
In a 71-week, double-blind study, Nova Nordisk—creators of the popular weight loss drug Wegovy—says their oral semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback